骨髓增殖性肿瘤 - Suppr

Myeloproliferative Neoplasms.

作者信息

Spivak Jerry L

机构信息

Johns Hopkins University School of Medicine, Baltimore, MD

出版信息

N Engl J Med. 2017 Aug 31;377(9):895-6. doi: 10.1056/NEJMc1708485.

DOI:10.1056/NEJMc1708485

PMID:28854086

Abstract

摘要

相似文献

Myeloproliferative Neoplasms.

N Engl J Med. 2017 Aug 31;377(9):895-6. doi: 10.1056/NEJMc1708485.

Association of JAK2 mutation status and cytogenetic abnormalities at diagnosis in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.

Am J Clin Pathol. 2012 Apr;137(4):677-8. doi: 10.1309/AJCP74TSVUHHAJFX.

Double-mutant myeloproliferative neoplasms.

Med Oncol. 2018 Aug 29;35(10):137. doi: 10.1007/s12032-018-1200-x.

The JAK2 V617F mutation in pediatric myeloproliferative neoplasms: how and when?

Pediatr Hematol Oncol. 2014 Mar;31(2):138-9. doi: 10.3109/08880018.2013.869288. Epub 2014 Jan 2.

[The discovery of JAK2 mutation has changed the diagnostic criteria of myeloproliferative neoplasms].

Zhonghua Yi Xue Za Zhi. 2008 Jul 1;88(25):1729-31.

Myeloproliferative Neoplasms.

N Engl J Med. 2017 Aug 31;377(9):894-5. doi: 10.1056/NEJMc1708485.

Myeloproliferative Neoplasms.

N Engl J Med. 2017 Aug 31;377(9):895. doi: 10.1056/NEJMc1708485.

Effect of mutation order on myeloproliferative neoplasms.

N Engl J Med. 2015 May 7;372(19):1865-6. doi: 10.1056/NEJMc1503143.

Effect of mutation order on myeloproliferative neoplasms.

N Engl J Med. 2015 May 7;372(19):1865. doi: 10.1056/NEJMc1503143.

[JAK2 mutation can be used in diagnosis of myeloproliferative diseases].

Zhonghua Yi Xue Za Zhi. 2006 Aug 29;86(32):2243-5.

引用本文的文献

Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM).

Leukemia. 2025 Apr 25. doi: 10.1038/s41375-025-02623-5.

Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP.

Mol Diagn Ther. 2024 Nov;28(6):665-668. doi: 10.1007/s40291-024-00737-7. Epub 2024 Aug 20.

Jak2 V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk.

Blood. 2024 Apr 11;143(15):1539-1550. doi: 10.1182/blood.2023022260.

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.

Cancers (Basel). 2023 Aug 29;15(17):4323. doi: 10.3390/cancers15174323.

Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis.

Adv Exp Med Biol. 2023;1408:273-290. doi: 10.1007/978-3-031-26163-3_15.

Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms.

Diagnostics (Basel). 2023 Mar 16;13(6):1123. doi: 10.3390/diagnostics13061123.

Dipeptidyl-peptidase 4 inhibitor increased and maintained platelet count in a patient with primary myelofibrosis.

EJHaem. 2021 May 20;2(3):551-554. doi: 10.1002/jha2.229. eCollection 2021 Aug.

Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemia.

Am J Blood Res. 2021 Oct 15;11(5):472-497. eCollection 2021.

Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition.

Blood Adv. 2022 Jan 25;6(2):611-623. doi: 10.1182/bloodadvances.2020002804.

Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms.

J Nucl Med. 2022 Jan;63(1):96-99. doi: 10.2967/jnumed.121.262206. Epub 2021 May 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Myeloproliferative Neoplasms.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献